期刊文献+

分化型黏膜下胃癌淋巴结转移的危险因素探讨 被引量:1

Study of the predictive factors of lymph node metastasis in differentiated submucosal gastric cancer
原文传递
导出
摘要 目的探讨分化型黏膜下胃癌淋巴结转移的危险因素,为EMR术后病理学诊断为黏膜下癌的患者制定合理术式提供理论依据。方法回顾性分析70例分化型黏膜下癌的临床病理资料,分析临床病理特征与淋巴结转移的关系。结果多因素分析表明,淋巴管癌栓和癌灶中存在未分化癌细胞成分(危险因素)与淋巴结转移有关,两指标组间差异有显著性(P<0.05)。两危险因素都存在者,淋巴结转移率为75.0%,无危险因素者,淋巴结转移率为0。在11例26个淋巴结转移的患者中,17个淋巴结转移在N1,9个淋巴结转移超过N1。结论淋巴管癌栓和癌灶中存在未分化癌细胞成分是分化型黏膜下癌淋巴结转移的独立危险因素。对于黏膜内癌行EMR术后病理学检查是黏膜下癌的患者,上述危险因素可作为判断是否需要进行附加手术的简单标准。 Objective To study the predictive factors of lymph node metastasis in differentiated submueosal gastric cancer ( DSMGC ) , and to establish an objective and rational criteria of indications of endoscopic mueosal resection for DSBGC. Methods Clinieopathologlcal data from 70 patients with differentiated submueosal gastric cancer were collected and the relationship between their clinieopathological characteristics and lymph node metastasis was retrospectively analyzed by univariate and multivariate analysis. Results Lymphatic vessel tumor embeli and presence of intermingled components of undifferentiated cancer cells ( risk factors ) were significantly associated with lymph node metastasis (P〈0.05). Patients with beth risk factors had lymph node metastasis rate of 75 % , patients with no risk factors had no lymph node metastasis. There were 26 lymph node metastases in 11 patients, and 17 of the metastasie lymph nodes were in N1 , while 9 metastatic lymph nodes were beyond N1. Conclusions Lymphatic vessel tumor emboli and presence of intermingled components of undifferentiated cancer cells were independently related to lymph node metastasis in differentiated submucosal gastric cancer. It is rational for the paitients with one or two independent risk clinicopathological characteristics to undergo an endoscopic mucosal resection.
出处 《中国普通外科杂志》 CAS CSCD 2008年第10期961-964,共4页 China Journal of General Surgery
基金 辽宁省教育厅资助项目(2004D182)
关键词 胃肿瘤/病理学 淋巴转移 危险因素 Stomach Neoplasms/pathol Lymphatic Metastasis Risk Factors
  • 相关文献

参考文献2

二级参考文献33

  • 1王夫景,于洪亮,杨茂鹏,高岩,黄跃南,张秀云,杨维良.胃癌腹腔微转移的研究及其临床意义[J].中国普通外科杂志,2005,14(10):725-727. 被引量:5
  • 2Kajitani T. The general rules for the gastric cancer study in surgery and pathology. Part Ⅰ. Clinical classification. Jpn J Surg 1981;11:127-139. 被引量:1
  • 3Inoue K, Tobe T, Kan N, Nio Y, Sakai M, Takekuchi E, Sugiyama T. Problems in the definition and treatment of early gastric cancer.Br J Surg 1991; 78:818-821. 被引量:1
  • 4Hioki K, Nakane Y, Yamamoto M. Surgical strategy for early gastric cancer. Br J Surg 1990; 77:1330-1334. 被引量:1
  • 5Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery and pathology. 12^th ed.Tokyo: Kanahara Shuppan 1993. 被引量:1
  • 6Hisamichi S, Sugawara N. Mass screening for gastric cancer by X-ray examination. Jpn J Clin Oncol 1984; 14:211-223. 被引量:1
  • 7Maehara Y, Okuyama T, Oshiro T, Baba H, Anai H, Akazawa K,Sugimachi K. Early carcinoma of the stomach. Surg Gynecol Obstet 1993; 177:593-597. 被引量:1
  • 8Sano T, Kobori O, Muto T. Lymph node metastasis from early gastric cancer: endoscopic resection of tumour. Br J Surg 1992;79:241-244. 被引量:1
  • 9Maehara Y, Orita H, Okuyama T, Moriguchi S, Tsujitani S,Korenaga D, Sugimachi K. Predictors of lymph node metastasis in early gastric cancer. Br J Surg 1992; 79:245-247. 被引量:1
  • 10Yamao T, Shirao K, Ono H, Kondo H, Saito D, Yamaguchi H.Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer 1996; 77:602-606. 被引量:1

共引文献80

同被引文献13

  • 1Torre L A, Bray F, Siegel R L, et al. Global cancer statis- tics, 2012[J]. CA Cancer J Clin, 2015, 65(2) : 87 - 108. DOI: 10.3322/eaae. 21262. 被引量:1
  • 2Shi J, Wei P K. Interleukin-8: A potent promoter of angio- genesis in gastric cancer[J]. Oneol Lett, 2016, 11 (2): 1043 - 1050. DOI: 10. 3892/ol. 2015. 4035. 被引量:1
  • 3Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2009 [J]. CA Cancer J Clin, 2009, 59(4):225-249. DOI: 10. 3322/eaac. 20006. 被引量:1
  • 4Liu L, Xu C, Hsieh J T, et al. DAB2IP in cancer[J]. On- cotarget, 2016, 7(4): 3766-3776. DOI: 10. 18632/onco- target. 6501. 被引量:1
  • 5Min J, Zaslavsky A, Fedele G, et al. An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coor- dinately activating Ras and nuclear factor-kappaB [ J ]. Nat Med, 2010, 16(3): 286-294. DOI: 10. 1038/nm. 2100. 被引量:1
  • 6Wu K, Wang B, Chen Y, et al. DAB2IP regulates the ehe-moresistance to pirarubicin and tumor recurrence of non-mus- cle invasive bladder cancer through STAT3/Twistl/P-glyco- protein signaling [ J ]. Cell Signal, 2015, 27 (12) : 2515 - 2523. DOI: 10. 1016/j. cellsig. 2015.09. 014. 被引量:1
  • 7Wang J, Zhu X, Hu J, et al. The positive feedback between Snail and DAB2IP regulates EMT, invasion and metastasis in eoloreetal cancer[ J]. Oncotarget, 2015, 6 (29) : 27427 - 27439. DOI: 10. 18632/oncotarget. 4861. 被引量:1
  • 8Zhang T, Shen Y, Chen Y, et al. The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect[J]. Int J Radiat Biol, 2015, 91 (4): 368 -378. DOI: 10.3109/09553002. 2015. 1001531. 被引量:1
  • 9Min J, Liu L, Li X, et al. Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer[J]. Sci Rep, 2015, 5: 16578. DOI: 10. 1038/srep16578. 被引量:1
  • 10Zhang X, Li N, Li X, et al. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma [ J ]. J Gastroenterol Hepatol, 2012, 27(6) : 1117 - 1125. DOI: 10. 1111/j. 1440-1746. 2011. 07049. x. 被引量:1

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部